[A case on hemodialysis with castration-resistant prostate cancer which responded to combination chemotherapy with docetaxel and prednisolone].
Gan To Kagaku Ryoho
; 40(9): 1245-7, 2013 Sep.
Article
en Ja
| MEDLINE
| ID: mdl-24047790
ABSTRACT
A 71-year-old man on hemodialysis was admitted for castration-resistant prostate cancer. He received chemotherapy with docetaxel(60mg/m2 every 3 weeks)and prednisolone(10mg/day). As severe adverse reactions due to chemotherapy were not encountered, he could receive chemotherapy in our outpatient clinic. A total of four courses of chemotherapy resulted in a 56% reduction in PSA, which was judged as PR. Chemotherapy with docetaxel and prednisolone can be safely carried out for a patient with castration-resistant prostate cancer, even while on hemodialysis with the usual dose of docetaxel.
Buscar en Google
Colección:
01-internacional
Asunto principal:
Neoplasias de la Próstata
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Fallo Renal Crónico
Límite:
Aged
/
Humans
/
Male
Idioma:
Ja
Revista:
Gan To Kagaku Ryoho
Año:
2013
Tipo del documento:
Article
País de afiliación:
Japón